Publication | Closed Access
Efficacy and safety of polyethylene glycol loxenatide as add‐on to metformin in patients with type 2 diabetes: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3b trial
26
Citations
27
References
2020
Year
The subcutaneous injection of PEX168 once a week can effectively, continuously and safely improve HbA1c levels in patients with T2D when combined with metformin.
| Year | Citations | |
|---|---|---|
Page 1
Page 1